Literature DB >> 11177696

Primary biliary cirrhosis with features of autoimmune hepatitis.

J Heathcote1.   

Abstract

The diagnosis of primary biliary cirrhosis (PBC) is made via a composite of clinical, laboratory, serologic, and histologic assessments, but within each parameter there exists a wide spectrum, so that the features of PBC are not always uniform. PBC is just one of several liver diseases thought to have an autoimmune basis. Therefore, it is not surprising, given the complexity of the immune response, that some patients thought to have PBC may have features of autoimmune hepatitis (AIH). Whether such patients have PBC with features of AIH, or antimitochondrial antibody-negative PBC, or another disease altogether, remains unclear.

Entities:  

Mesh:

Year:  2001        PMID: 11177696     DOI: 10.1007/s11894-001-0042-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  37 in total

1.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

2.  Primary biliary cirrhosis.

Authors:  E H AHRENS; M A PAYNE; H G KUNKEL; W J EISENMENGER; S H BLONDHEIM
Journal:  Medicine (Baltimore)       Date:  1950-12       Impact factor: 1.889

3.  Autoimmune cholangitis within the spectrum of autoimmune liver disease.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

4.  Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial.

Authors:  M Leuschner; K P Maier; J Schlichting; S Strahl; G Herrmann; H H Dahm; H Ackermann; J Happ; U Leuschner
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

5.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

6.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

7.  Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.

Authors:  P T Donaldson; D G Doherty; K M Hayllar; I G McFarlane; P J Johnson; R Williams
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

8.  [A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)].

Authors:  G Brunner; O Klinge
Journal:  Dtsch Med Wochenschr       Date:  1987-09-18       Impact factor: 0.628

9.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.

Authors:  B D Clifford; D Donahue; L Smith; E Cable; B Luttig; M Manns; H L Bonkovsky
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.